NewAmsterdam Pharma Company
NAMS • NASDAQ • Stock Fundamentals
NewAmsterdam Pharma Company is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Harvey Davidson Facp., with a market cap of $3.5B.
Market Cap$3.5B
Employees29.0
CEOMichael Harvey Davidson Facp.
CountryNetherlands
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
NewAmsterdam Pharma Company FAQ
Common questions about NewAmsterdam Pharma Company
NewAmsterdam Pharma Company (NAMS) has a market capitalization of $3.5B and trades on NASDAQ.
NewAmsterdam Pharma Company has approximately 29 employees.